Johnson & Johnson MedTech is reportedly considering selling its DePuy Synthes Orthopaedics business, potentially valued at over $20 billion. The move follows J&J’s October 2025 announcement to separate the business to enhance strategic focus and stakeholder value, with “big buyout firms” and other medtech companies reportedly interested in the acquisition.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit
Johnson & Johnson MedTech is reportedly considering selling its DePuy Synthes Orthopaedics business, potentially valued at over $20 billion. The move follows J&J’s October 2025 announcement to separate the business to enhance strategic focus and stakeholder value, with “big buyout firms” and other medtech companies reportedly interested in the acquisition.